HEALing Communities Study Consortium,Jeffrey H Samet,Nabila El-Bassel,T John Winhusen,Rebecca D Jackson,Emmanuel A Oga,Redonna K Chandler,Jennifer Villani,Bridget Freisthler,Joella Adams,Arnie Aldridge,Angelo Angerame,Denise C Babineau,Sarah M Bagley,Trevor J Baker,Peter Balvanz,Carolina Barbosa,Joshua Barocas,Tracy A Battaglia,Dacia D Beard,Donna Beers,Derek Blevins,Nicholas Bove,Carly Bridden,Jennifer L Brown,Heather M Bush,Joshua L Bush,Ryan Caldwell,Katherine Calver,Deirdre Calvert,Aimee N C Campbell,Jane Carpenter,Rachel Caspar,Deborah Chassler,Joan Chaya,Debbie M Cheng,Chinazo O Cunningham,Anindita Dasgupta,James L David,Alissa Davis,Tammy Dean,Mari-Lynn Drainoni,Barry Eggleston,Laura C Fanucchi,Daniel J Feaster,Soledad Fernandez,Wilson Figueroa,Darcy A Freedman,Patricia R Freeman,Caroline E Freiermuth,Eric Friedlander,Kitty H Gelberg,Erin B Gibson,Louisa Gilbert,LaShawn Glasgow,Dawn A Goddard-Eckrich,Stephen Gomori,Dawn E Gruss,Jennifer Gulley,Damara Gutnick,Megan E Hall,Nicole Harger Dykes,Sarah L Hargrove,Kristin Harlow,Aumani Harris,Daniel Harris,Donald W Helme,JaNae Holloway,Juanita Hotchkiss,Terry Huang,Timothy R Huerta,Timothy Hunt,Ayaz Hyder,Van L Ingram,Tim Ingram,Emily Kauffman,Jennifer L Kimball,Elizabeth N Kinnard,Charles Knott,Hannah K Knudsen,Michael W Konstan,Sarah Kosakowski,Marc R Larochelle,Hannah M Leaver,Patricia A LeBaron,R Craig Lefebvre,Frances R Levin,Nikki Lewis,Nicky Lewis,Michelle R Lofwall,David W Lounsbury,Jamie E Luster,Michael S Lyons,Aimee Mack,Katherine R Marks,Stephanie Marquesano,Rachel Mauk,Ann Scheck McAlearney,Kristin McConnell,Margaret L McGladrey,Jason McMullan,Jennifer Miles,Rosie Munoz Lopez,Alisha Nelson,Jessica L Neufeld,Lisa Newman,Trang Q Nguyen,Edward V Nunes,Devin A Oller,Carrie B Oser,Douglas R Oyler,Sharon Pagnano,Theodore V Parran,Joshua Powell,Kim Powers,William Ralston 3rd,Kelly Ramsey,Bruce D Rapkin,Jennifer G Reynolds,Monica F Roberts,Will Robertson,Peter Rock,Emma Rodgers,Sandra Rodriguez,Maria Rudorf,Shawn Ryan,Pamela Salsberry,Monika Salvage,Nasim Sabounchi,Merielle Saucier,Caroline Savitzky,Bruce Schackman,Elizabeth Schady,Eric E Seiber,Aimee Shadwick,Abigail Shoben,Michael D Slater,Svetla Slavova,Drew Speer,Joel Sprunger,Laura E Starbird,Michele Staton,Michael D Stein,Danelle J Stevens-Watkins,Thomas J Stopka,Ann Sullivan,Hilary L Surratt,Rachel Sword Cruz,Jeffery C Talbert,Jessica L Taylor,Katherine L Thompson,Nathan Vandergrift,Rachel A Vickers-Smith,Deanna J Vietze,Daniel M Walker,Alexander Y Walley,Scott T Walters,Roger Weiss,Philip M Westgate,Elwin Wu,April M Young,Gary A Zarkin,Sharon L Walsh

Abstract:Background: Evidence-based practices for reducing opioid-related overdose deaths include overdose education and naloxone distribution, the use of medications for the treatment of opioid use disorder, and prescription opioid safety. Data are needed on the effectiveness of a community-engaged intervention to reduce opioid-related overdose deaths through enhanced uptake of these practices. Methods: In this community-level, cluster-randomized trial, we randomly assigned 67 communities in Kentucky, Massachusetts, New York, and Ohio to receive the intervention (34 communities) or a wait-list control (33 communities), stratified according to state. The trial was conducted within the context of both the coronavirus disease 2019 (Covid-19) pandemic and a national surge in the number of fentanyl-related overdose deaths. The trial groups were balanced within states according to urban or rural classification, previous overdose rate, and community population. The primary outcome was the number of opioid-related overdose deaths among community adults. Results: During the comparison period from July 2021 through June 2022, the population-averaged rates of opioid-related overdose deaths were similar in the intervention group and the control group (47.2 deaths per 100,000 population vs. 51.7 per 100,000 population), for an adjusted rate ratio of 0.91 (95% confidence interval, 0.76 to 1.09; P = 0.30). The effect of the intervention on the rate of opioid-related overdose deaths did not differ appreciably according to state, urban or rural category, age, sex, or race or ethnic group. Intervention communities implemented 615 evidence-based practice strategies from the 806 strategies selected by communities (254 involving overdose education and naloxone distribution, 256 involving the use of medications for opioid use disorder, and 105 involving prescription opioid safety). Of these evidence-based practice strategies, only 235 (38%) had been initiated by the start of the comparison year. Conclusions: In this 12-month multimodal intervention trial involving community coalitions in the deployment of evidence-based practices to reduce opioid overdose deaths, death rates were similar in the intervention group and the control group in the context of the Covid-19 pandemic and the fentanyl-related overdose epidemic. (Funded by the National Institutes of Health; HCS ClinicalTrials.gov number, NCT04111939.).

Community Support for Harm Reduction and Treatment of Opioid Use Disorder

Public support for harm reduction: A population survey of Canadian adults

Barriers and Facilitators to Harm Reduction for Opioid Use Disorder: A Qualitative Study of People With Lived Experience

Opioid Use Disorder Stigma Reduction Through Story Telling Narrative and Sharing: a Qualitative Review and Lessons Learned

Individual, interpersonal, and neighborhood measures associated with opioid use stigma: Evidence from a nationally representative survey

"They make it too hard and too many hoops to jump": system and organizational barriers to drug treatment during epidemic rates of opioid overdose

Harm Reduction and Treatment Among People at High Risk of Overdose

Stimulant use among patients in opioid treatment settings: Provider perspectives

Effects of the Communities that Heal (CTH) intervention on perceived opioid-related community stigma in the HEALing Communities Study: results of a multi-site, community-level, cluster-randomized trial

A Perspective from the Field: Five Interventions to Combat the Opioid Epidemic and Ending the Dichotomy of Harm-reduction versus Abstinence-Based Programs

Occupational and Personal Challenges During the Opioid Crisis: Understanding First Responders' Experiences and Viewpoints of Clients with Opioid Use Disorder

Identifying Provider Barriers to the Implementation of Opioid Harm Reduction Methods: An Initial Narrative Review

Navigating new norms: Addiction specialists' perspectives on opioid use disorder treatments and policy challenges in the fentanyl era

State-Targeted Funding and Technical Assistance to Increase Access to Medication Treatment for Opioid Use Disorder

Patient and navigator experiences with the opioid use disorder treatment system in Philadelphia, PA

Medications for Opioid Use Disorder in the Criminal/Legal System: Knowledge, Beliefs, and Attitudes Among Rural Community-Based Stakeholders

What Are Community Supervision Officers' Knowledge and Views of Naloxone? An Exploratory Study

Negative attitudes about medications for opioid use disorder among criminal legal staff

Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths

Reducing perceived barriers to scaling up overdose education and naloxone distribution and medications for opioid use disorder in the United States in the HEALing (Helping End Addiction Long-Term®) communities study